Rethinking Optimal Immunogens to Face SARS-CoV-2 Evolution Through Vaccination

Area of Science:

• Virology
• Immunology
• Vaccinology

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, has had profound global health and economic impacts.
• Current vaccines, primarily targeting the full Spike protein, show high efficacy but face challenges from viral evolution and waning immunity.
• Repeated vaccination and infection can lead to immune imprinting, potentially reducing responses to subsequent antigen exposures.

Purpose of the Study:

• To explore optimal strategies for COVID-19 vaccine boosters in the context of viral evolution and immune imprinting.
• To highlight the importance of targeting the Receptor Binding Domain (RBD) of SARS-CoV-2 for booster vaccine development.
• To investigate methods for minimizing immune imprinting and maximizing neutralizing antibody responses.

Main Methods:

• Review and analysis of existing data on SARS-CoV-2 evolution and vaccine responses.
• Focus on the Receptor Binding Domain (RBD) as a key target for neutralizing antibodies.
• Consideration of immunofusing and computational approaches to enhance vaccine strategies.

Main Results:

• The RBD accumulates most SARS-CoV-2 mutations, making it crucial for targeting new variants.
• Immune imprinting is a significant factor influencing immune responses after repeated vaccinations or infections.
• Targeting the evolving RBD in booster vaccines offers a promising approach to overcome current limitations.

Conclusions:

• Developing booster vaccines focused on the evolving RBD of SARS-CoV-2 is essential for long-term COVID-19 control.
• Combining RBD-targeted strategies with immunofusing and computational methods can potentially minimize immune imprinting.
• Optimizing booster strategies is critical for enhancing neutralizing immune responses and overall vaccine efficacy against SARS-CoV-2 variants.